EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin

NCT01119300 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

455

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Atrial Fibrillation

Interventions

OTHER: Genotype-guided dosing algorithm
OTHER: Standard care

Sponsor

Utrecht Institute for Pharmaceutical Sciences

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]